Citation Impact
Citing Papers
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
2010
Pathogenesis of type 2 diabetes mellitus
2004
Thiazolidinediones
2004 Standout
Abdominal obesity and metabolic syndrome
2006 StandoutNature
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and Women Aged 70 to 79: The Health, Aging and Body Composition Study
2002
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Pathophysiology of Prediabetes
2011
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization
2004
Plasma Acylcarnitine Profiles Suggest Incomplete Long-Chain Fatty Acid β-Oxidation and Altered Tricarboxylic Acid Cycle Activity in Type 2 Diabetic African-American Women
2009
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
Exercise Standards for Testing and Training
2013 Standout
Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men
2004 Standout
Role of adiponectin in human skeletal muscle bioenergetics
2006
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome—an analysis by structural equation modelling
2002
Inflammation and insulin resistance
2006 Standout
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity
2008
AGA technical review on nonalcoholic fatty liver disease
2002
Macrophage-specific PPARγ controls alternative activation and improves insulin resistance
2007 StandoutNature
Mitochondria: In Sickness and in Health
2012 Standout
Obesity
2005 Standout
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
2005
Orphan nuclear receptors: therapeutic opportunities in skeletal muscle
2006
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The metabolic syndrome
2005 Standout
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Increased Levels of Plasma Acylcarnitines in Obesity and Type 2 Diabetes and Identification of a Marker of Glucolipotoxicity
2010
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Intramuscular lipid content is increased in obesity and decreased by weight loss
2000
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Type 2 diabetes
2017 Standout
Rethinking schizophrenia
2010 StandoutNature
Dysfunctional fat cells, lipotoxicity and type 2 diabetes
2004
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Is visceral obesity the cause of the metabolic syndrome?
2006
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study
2002
Increased Fat Intake, Impaired Fat Oxidation, and Failure of Fat Cell Proliferation Result in Ectopic Fat Storage, Insulin Resistance, and Type 2 Diabetes Mellitus
2002
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Fatty acid metabolism in obesity and type 2 diabetes mellitus
2003
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Autophagy and Aging
2011 Standout
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex
2003
Exercise‐Induced Reduction in Obesity and Insulin Resistance in Women: a Randomized Controlled Trial
2004
Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update
2018
Mechanisms of fatty acid-induced inhibition of glucose uptake.
1994 Standout
What We Talk About When We Talk About Fat
2014 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Insulin Resistance and Improvements in Signal Transduction
2006
Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α
2006 Standout
Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects—experiences from relatives and twin studies
2003
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients
2004
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Metabolic and molecular basis of insulin resistance
2003
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
2012
AMPK: a nutrient and energy sensor that maintains energy homeostasis
2012 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Interplay between Lipids and Branched-Chain Amino Acids in Development of Insulin Resistance
2012
Increased intramuscular lipid storage in the insulin-resistant and endurance-trained state
2005
Metabolic syndrome: Definition, pathophysiology, and mechanisms
2005
Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss
1999
Relationship Between Insulin Sensitivity and Sphingomyelin Signaling Pathway in Human Skeletal Muscle
2004
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Dose-Response Effect of Elevated Plasma Free Fatty Acid on Insulin Signaling
2005
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006 Standout
Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients
2004
Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men
2000
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults
2011 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
2009 Standout
Attenuation of skeletal muscle and strength in the elderly: The Health ABC Study
2001
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Dysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
2002 Standout
Revisiting the diacylglycerol‐induced insulin resistance hypothesis
2012
Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ
2002
Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach
2004
The Atherogenic Lipoprotein Profile Associated With Obesity and Insulin Resistance Is Largely Attributable to Intra-Abdominal Fat
2003
Rapid and Weight-Independent Improvement of Glucose Tolerance Induced by a Peptide Designed to Elicit Apoptosis in Adipose Tissue Endothelium
2012
Normal insulin sensitivity and IMCL content in overweight humans are associated with higher fasting lipid oxidation
2002
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
2008 Standout
Fatty Acids, Obesity, and Insulin Resistance: Time for a Reevaluation
2011
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Point: Visceral Adiposity Is Causally Related to Insulin Resistance
2005
Pioglitazone Reduces Hepatic Fat Content and Augments Splanchnic Glucose Uptake in Patients With Type 2 Diabetes
2003
Skeletal Muscle Mitochondria in Insulin Resistance: Differences in Intermyofibrillar Versus Subsarcolemmal Subpopulations and Relationship to Metabolic Flexibility
2010
Muscle-specific PPARγ-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones
2003
Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role ofPGC1andNRF1
2003 Standout
Mitochondrial Dysfunction and Type 2 Diabetes
2005 StandoutScience
Exercise and the metabolic syndrome with weight regain
2010
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization
2004
Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase
2011
Visceral Adipose Tissue Is an Independent Correlate of Glucose Disposal in Older Obese Postmenopausal Women1
2000
The Concurrent Accumulation of Intra-Abdominal and Subcutaneous Fat Explains the Association Between Insulin Resistance and Plasma Leptin Concentrations
2002
Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus
2008
Insulin Receptor Substrates Irs1 and Irs2 Coordinate Skeletal Muscle Growth and Metabolism via the Akt and AMPK Pathways
2010
Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase
2004 StandoutScience
Genetic activation of pyruvate dehydrogenase alters oxidative substrate selection to induce skeletal muscle insulin resistance
2014
Abdominal Visceral and Subcutaneous Adipose Tissue Compartments
2007 Standout
Sarcopenia: European consensus on definition and diagnosis
2010 Standout
Effect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men*
2000
Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance
2000
Intramyocellular Lipid Is Associated With Resistance to In Vivo Insulin Actions on Glucose Uptake, Antilipolysis, and Early Insulin Signaling Pathways in Human Skeletal Muscle
2001
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes
2017
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 StandoutScience
A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
2003
Works of D. E. Kelley being referenced
Skeletal muscle fat oxidation: timing and flexibility are everything
2005
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
1999
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
2000